Testing effectiveness (Phase 2)Study completedNCT01158235
What this trial is testing
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)
Who this might be right for
Nasal Carriers MRSA
Lytix Biopharma AS 24